Biocomposite materials and methods for making the same

Details Biocomposite materials and methods for making the same Biocomposite materials and methods for making the same

2007-12-25

2007-12-25

Woodward, Michael P. (Department: 1615)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Particulate form

C424S400000, C424S489000, C424S490000

Reexamination Certificate

active

10326201

ABSTRACT:
A particle (and a composition that includes a plurality of the particles) that includes at least one polypeptide molecule and at least one polymer covalently bound to the polypeptide molecule so as to form a polymer shell substantially encompassing the polypeptide molecule, wherein the particle does not define a dimension greater than about 1 μm. One example for making the particle includes modifying the polypeptide molecule to provide α, β-ethylenically unsaturated terminal functional groups, mixing the modified polypeptide molecule with a silicon-containing polymerizable compound, and subjecting the resulting mixture to conditions sufficient for polymerizing the polymerizable compound to form the particle.

REFERENCES:
patent: 3985616 (1976-10-01), Weaver et al.
patent: 4371612 (1983-02-01), Matsumoto et al.
patent: 4665028 (1987-05-01), Amotz
patent: 4727030 (1988-02-01), Ishimura et al.
patent: 5281355 (1994-01-01), Tsaur et al.
patent: 5281356 (1994-01-01), Tsaur et al.
patent: 5441660 (1995-08-01), Tsaur et al.
patent: 5482996 (1996-01-01), Russell et al.
patent: 5498421 (1996-03-01), Grinstaff et al.
patent: 5665383 (1997-09-01), Grinstaff et al.
patent: 5718915 (1998-02-01), Virtanen et al.
patent: 5719039 (1998-02-01), Dordick et al.
patent: 5914367 (1999-06-01), Dordick et al.
patent: 5916790 (1999-06-01), Enevold
patent: 6020200 (2000-02-01), Enevold
patent: 6291582 (2001-09-01), Dordick et al.
patent: 6337089 (2002-01-01), Yoshioka et al.
patent: 2001/0050217 (2001-12-01), Uehara et al.
patent: 2003/0171804 (2003-09-01), Krause
Abuchowski et al., “Alteration of Immunological Properties of Bovine Serum Albumin by Covalent Attachment of Polyethylene Glycol” The Journal of Biological Chemistry vol. 252, 11, Jun. 10, 1977 pp. 3578-3581.
Ito et al.,Biotechnol. Prog.9(2):128-130 (1993).
Jain et al.,J. Am. Chem. Soc.120(43):11092-11095 (1998).
Kim et al.,Biotechnol. Prog.18(3):551-555 (2002).
Marinakos et al.,J. Phys. Chem B105(37):8872-8876 (2001).
Novick et al.,Chem. Mater.10(4):955-958 (1998).
Novick et al.,Biotechnology and Bioengineering68(6):665-671(2000).
Novick et al.,Biomaterials23:441-448 (2002).
Paradkar et al.,J. Am. Chem. Soc.116:5009-5010 (1994).
Pina et al.,Biotechnology Techniques3(5):333-338 (1989).
Yang et al.,J. Am. Chem. Soc.117(17):4843-4850 (1995).
Avnir et al., “Recent bio-applications of sol-gel materials,”Journal of Materials Chemistry16:1013-1030, 2006.
Bailey and Ollis, “Immobilized-Enzyme Technology,”Biochemical Engineering Fundamentals(2d ed., McGraw-Hill Book Company), pp. 180-189, 1986.
Ebsworth, “Silicon Bound to Elements of Group VI,”Volatile Silicon Compounds(Pergamon Press) p. 137, 1963.
Greene and Wuts, “Protection for the Carboxyl Group,”Protective Groups in Organic Synthesis(3d ed., John Wiley & Sons, Inc.), pp. 428-429, 1999.
Rochow, “The Simple Covalent Compounds of Silicon,”An Introduction to the Chemistry of Silicones(2d ed., John Wiley & Sons, Inc.), pp. 16, 1946 and 1951.
Definition of Macroporous Polymer fromPure Appl. Chem.76(4):889-906, 2004.
Bode et al., “Crude Aminoacylase FromAspergillussp. Is a Mixture of Hydrolases,” Biotechnol. Bioeng. 84:710-713, 2003.
Cabriol et al., “Immobilized Hydroxynitrile Lyases for Enantioselective Synthesis of Cyanohydrins: Sol-Gels and Cross-Linked Enzyme Aggregates,”Adv. Synth. Catal.348:1645-1654, 2006.
Cao et al., “Cross-Linked Enzyme Aggregates: A Simple and Effective Method for the Immobilization of Penicillin Acylase,”Organic Letters2(10):1361-1364, 2000.
Cao et al., “Cross-linked aggregates of penicillin acylase: robust catalysts for the synthesis of β-lactam antibiotics,”Journal of Molecular Catalysis11:665-670, 2001.
Cao et al., “Immobilised enzymes: carrier-bound or carrier-free?,”Current Opinion in Biotechnology14:387-394, 2003.
Chmura et al., “Cross-Linked Aggregates of the Hydroxynitrile Lyase fromManihot esculenta: Highly Active and Robust Biocatalysts,”Adv. Synth. Catal. 348:1655-1661, 2006.
Fishback et al., “Miniature Biofuel Cells with Improved Stability Under Continuous Operation,”Electroanalysis18(19-20):2016-2022, 2006.
Hobbs et al., “Continuous kinetic resolution catalysed by cross-linked enzyme aggregates, ‘CLEAs’, in Supercritical CO2,”Green Chem. 8:816-821, 2006.
Kim et al., “Preperation of biocatalytic nanofibres with high active and stability via enzyme aggregate coating on polymer nanofibres,”Nanotechnology16:S382-388, 2005.
López-Serrano et al., “Cross-linked enzyme aggregates with enhanced activity: application to lipases,”Biotechnology Letters24:1379-1383, 2002.
Mateo et al., “A Newm Mild Cross-linking Methodology to Prepare Cross-Linked Enzyme Aggregates,”Biotechnology and Bioengineering86(3):273-276, 2004.
Mateo et al., “Stabilisation of oxygen-labile nitrilases via co-aggregation with poly(ethyleneimine),”Journal of Molecular Catalysis B: Enzymatic38:154-157, 2006.
Mateo et al., “Synthesis of enantiomerically pure (S)-mandelic acid using an oxynitrilase-nitrilase bienzymatic cascade: a nitrilase surprisingly shows nitrile hydratase activity,”Tetrahedron: Asymmetry17:320-323, 2006.
Schoevaart et al., “Preperation, Optimization, and Structures of Cross-Linked Enzyme Aggregates (CLEAs),”Biotechnology and Bioengineering87(6):754-762, 2004.
Sheldon et al., “CLEAS: An effective technique for enzyme immobilization,”Specialty Chemicals Magazine, pp. 40-42, Jul./Aug. 2003.
Sheldon et al., “Cross-linked enzyme aggregates (CLEAs): A novel and versatile method for enzyme immobilization (a review),”Biocatalysis and Biotransformation23(3/4):141-147, 2005.
Sheldon et al., “Cross-linked enzyme aggregates (CLEAs),”Methods in Biotechnology 22. Immobilization of enzymes an cells(2nded.), Humana Press, Totowa, NJ, pp. 31-45, 2006.
Sheldon, “Immobilization of Enzymes as Cross-Linked Enzyme Aggregates: A Simple Method for Improving Performance,”Biocatalysis in the Pharmaceutical and Biotechnology Industries, CRC Press, Taylor & Francis Group, Boca Raton, FL, pp. 351-362, 2006.
Sheldon, et al., “Use of Cross-Linked Enzyme Aggregates (CLEAs) for performing biotransformations,”Chemistry Today25(I):62-67, 2007.
van Langen et al., “Penicillin Acylase Catalysed Synthesis of Ampicillin in Hydrophilic Organic Solvents,”Adv. Synth. Catal., 645:797-807, 2003.
van Langen et al., “Cross-Linked Aggregates of (R)-Oxynitrilase: A Stable, Recyclable Biocatalyst for Enantioselective Hydrocyanation,”Organic Letters7(2):327-329, 2005.

Affiliated with

Also associated with

Rating

Biocomposite materials and methods for making the same does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biocomposite materials and methods for making the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biocomposite materials and methods for making the same will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3836219